undamentalytics Newsletter
Sign in

Albemarle Corporation revenue

Albemarle Corporation's revenue was $5.14bn in fiscal 2025, down 4.4% on the year before. Since fiscal 2009 ($2.01bn) it has grown at a compound 6.1% a year. Over the last twelve months it was $5.91bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue2,0052,3632,8692,5192,3942,4462,8262,6773,0723,3753,5893,1293,3287,3209,6175,3785,1435,908
Growth on the year before—+17.8%+21.4%−12.2%−5.0%+2.1%+15.6%−5.3%+14.7%+9.9%+6.4%−12.8%+6.4%+120.0%+31.4%−44.1%−4.4%—
Gross profit4847429558998507718609701,1061,2171,2589959983,0751,186636691,407
Gross margin24.1%31.4%33.3%35.7%35.5%31.5%30.4%36.2%36.0%36.1%35.0%31.8%30.0%42.0%12.3%1.2%13.0%23.8%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue Share YoY
China $2B 39.4% ▲ 3.3%
Other Foreign Countries $1.1B 20.9% ▲ 6.3%
United States $890M 17.3% ▼ 1.3%
South Korea $790M 15.4% ▼ 13.5%
Japan $360M 7.0% ▼ 39.0%

From Albemarle Corporation's 10-K filed February 11, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Specialty Chemicals: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Albemarle Corporation $5.91bn 18.3% -15.1%
Axalta Coating Systems Ltd. $5.17bn 0.1% 0.3%
RPM International Inc $7.97bn 6.0% 2.8%
Cabot Corp $3.63bn -4.7% -3.8%
Fuller H B Co $3.55bn 1.5% -0.1%
Element Solutions Inc $3.49bn 39.6% 14.4%

Compare with peers

Head to head: ALB vs AXTAALB vs RPMALB vs CBT

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Albemarle Corporation's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Albemarle Corporation.